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Background: Many people with a terminal illness would prefer to die at home. A new palliative rapid response service
(RRS) provided by a large hospice provider in South East England was evaluated (2010) to provide evidence of impact
on achieving preferred place of death and costs. The RRS was delivered by a team of trained health care assistants and
available 24/7. The purpose of this study was to (i) compare the characteristics of RRS users and non-users, (ii) explore
differences in the proportions of users and non-users dying in the place of their choice, (iii) monitor the whole system
service utilisation of users and non-users, and compare costs.
Methods: All hospice patients who died with a preferred place of death recorded during an 18 month period were
included. Data (demographic, preferences for place of death) were obtained from hospice records. Dying in preferred
place was modelled using stepwise logistic regression analysis. Service use data (period between referral to hospice and
death) were obtained from general practitioners, community providers, hospitals, social services, hospice, and
costs calculated using validated national tariffs.
Results: Of 688 patients referred to the hospice when the RRS was operational, 247 (35.9 %) used it. Higher proportions
of RRS users than non-users lived in their own homes with a co-resident carer (40.3 % vs. 23.7 %); more non-users lived
alone or in residential care (58.8 % vs. 76.3 %). Chances of dying in the preferred place were enhanced 2.1 times by
being a RRS user, compared to a non-user, and 1.5 times by having a co-resident carer, compared to living at home
alone or in a care home. Total service costs did not differ between users and non-users, except when referred to hospice
very close to death (users had higher costs).
Conclusions: Use of the RRSwas associatedwith increased likelihood of dying in the preferred place. The RRS is cost neutral.
Trial registration:Current controlled trials ISRCTN32119670, 22 June 2012.
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Many people faced with terminal illness would prefer to
die at home [1–3], but less than a third do so in the
United Kingdom (UK); most die in National Health
Service (NHS) hospitals [2, 4, 5]. Patients are more likely
to die at home if their carers receive professional sup-
port [6, 7]. The Department of Health (DH) policy guid-
ance stresses the importance of giving people more
choice over where they die and tasks NHS Trusts to
provide services 24/7 to enable people to receive the
care they needed to die at home [8].* Correspondence: h.gage@surrey.ac.uk
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ted to hospital because of a crisis that could not be
resolved at home, such as uncontrolled symptoms, carer
fear or stress, and not having medication available [9].
Research has shown that patients who spend more time
in hospital or hospice during their illness are more likely
to die there [7], so keeping patients out of inpatient
facilities may help improve the likelihood that patients
die at home. Evidence is lacking, however, on the costs
of palliative care in different settings, creating uncertain-
ties for service commissioners [5, 8, 10–12].
Independent hospices play an important role in end-
of-life care, providing inpatient, day and domiciliary care
[5]. Typically, hospice services integrate with other local
providers, and many different models of care exist [13].s distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Gage et al. BMC Palliative Care  (2015) 14:75 Page 2 of 11Rapid response services (RRS) provide intense care over
relatively short periods when crises arise, and work
alongside regular domiciliary services that offer longer
term support, to help avoid admission to hospice or
hospital. Three studies in the UK [10, 14, 15] found that
RRSs resulted in higher proportions of patients dying at
home, compared to the national average (42 %, 41 %,
29 % vs. 21 %) [4]. However, these were small evalua-
tions, and further research is required to provide a firm
evidence base.
This paper presents the results of an evaluation of a
new RRS introduced by Pilgrims Hospices in South
East England in 2010 [16]. The objectives were to (i)
compare the characteristics of users of the RRS with
those of people that did not use it, (ii) explore differ-
ences between users and non-users in the proportions
of patients dying in the place of their choice, and (iii)
monitor the overall service utilisation of users and non-
users, and compare costs.
Methods
Design
Pilgrims Hospice services are delivered from three cen-
tres serving contiguous communities (total population
600,000) in the county of Kent. In each centre, the
hospice provides a 16-bed inpatient ward, day hospice
services and community outreach. The study followed a
randomised stepped wedge design. The new RRS was
rolled out sequentially to the three areas (order deter-
mined randomly using a simple probabilistic model),
starting January 2010, with six months between the start
of provision in each area. The study continued for six
months after the RRS was introduced in the third area
(total of 18 months). The time before the introduction
of the RRS was deemed the control period, i.e. 0, 6 and
12 months in Areas 1, 2 and 3 respectively (Fig. 1). Once
available in an area, any patients referred to the hospice
in that area could access the RRS, although not all pa-
tients did. A comparison of the intervention (when RRS
was provided) and control (no RRS available) conditions,Fig. 1 Timeline of introduction of the Rapid Response Serviceand carer outcomes and experiences are reported else-
where [17]. This paper focusses on the time when the
RRS was available in each area and a comparison of the
people using it with those who did not.RRS intervention
The RRS was developed in line with best practice and
following a review of available evidence on hospice-at-
home and other RRSs [13]. It is delivered by a team of
experienced health care assistants (band 3), who were
trained by the hospice and supported by the full hos-
pice multidisciplinary team. The RRS serves all three
areas and has access to a service co-ordinator, medical
advice, and equipment carried by car. The team re-
sponds rapidly 24/7 to crises in patients’ homes (in-
cluding care homes). Patients’ needs and prognosis, and
family circumstances are assessed, including patient/
family preferences. Hand-on care is provided in coord-
ination with other community services. A full descrip-
tion of the establishment of the RRS is reported
separately [18].Participants
All patients newly referred to any of the three centres
(from any source) for any hospice service during the
18 month study period were identified from the hospice
database and included, although the analysis reported in
this paper only refers to patients recruited after the RRS
had been introduced in the area in which they lived.
Patients were ineligible if still alive at the end of the
18 month data collection period (because place of death
and total services utilisation were not known), or if
already registered with the hospice in Areas 2 and 3
when the RRS was introduced (because they crossed
between control and intervention conditions). Amongst
eligible patients, those without a recorded preferred place
of death (PPD) in the hospice notes were excluded from
the analysis.
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Hospice records of individual patients were accessed
retrospectively to obtain data on: age (calculated from
date of birth collected at first hospice consultation); sex;
residential situation (own home alone/with a carer, resi-
dential care); date referred to hospice; initial (recorded at
first hospice assessment) PPD (own home, care home,
hospice, hospital, other); final PPD (if subsequent changes
recorded); date of death; actual place of death (APD).
Number of days in the study was computed (date of death
minus date referred to hospice) and grouped (<=2; 3-14,
15-30, 31-60, >60 days). Initial and final PPD were
compared with APD to establish whether or not patients
achieved their PPD.
Analysis
Data were transferred to SPSS version 20 (IBM SPSS
Statistics for Windows) for analysis. Excluded patients
(no recorded PPD) were compared with those included
with respect to age, sex, place of residence, APD. The
characteristics of RRS users were compared with pa-
tients registered with the hospice in an area with a RRS
but who did not access it (non-users). Comparisons
(users vs. non-users) of continuous variables (age and
days in study) were made using t tests; other variables
were compared using chi-square tests. The factors (age,
sex, area, days in study, initial PPD, residential situation)
associated with achieving the PPD were explored in two
stages: first using bivariate analysis and then using step-
wise (backward elimination) logistic regression modelling
and including RRS user/non-user as a dummy variable.
Variables entered into the model were: RRS user (vs. non-
user), sex (female), age, live at home alone or with carer
(vs. live in care home), Area 2 or Area 3 (vs. Area 1), num-
ber of days in study (between referral to hospice and death
using 1, 8, 21, 45, 75 for each of the five time groups). The
five category initial PPD was recoded into 2 variables:
preference for own home (Yes/No); preference for care
home (Yes/No).
Economic evaluation
The costs of the RRS were calculated on an individual
patient basis from hospice records of the number of
visits and time spent in patients’ homes. To assess the
extent to which the RRS substituted for other forms of
health and social care, service utilisation data were
collected for all participants for the time that they were
in the study (referral to hospice to date of death) from
seven providers: general practitioners; community ser-
vices; acute (hospital) services (A&E, inpatient nights,
outpatient appointments, day hospital); Marie Curie home
sitting; out-of-hours services (GP/nurse home visits, tele-
phone advice, ‘walk-in’ attendances; social services received;
hospice services, other than the RRS (home, outpatient,inpatient, day hospice). The number of contacts was
summed within each service type. Some GPs did not re-
turn service use data, and missing items were filled using
the mean values for patients with data and who were in
the study for the same time period. All other service use
data were complete.
Contacts with health care staff/services were converted
to costs in British pounds, 2010, using validated NHS
unit costs, inclusive of oncosts and overheads [19].
Discussion with the hospice finance director confirmed
that it was appropriate to apply NHS rates to hospice
services. Units of service use (visits, nights, hours etc.)
were multiplied by the relevant unit cost to obtain the
total cost per service use item per participant. Social ser-
vices provided the cost of social care packages which
were compared with national tariffs [19] and found to be
comparable, and hence were used as supplied. Costs of
individual service use items were summed within service
use types, and the grand total cost was calculated.
The distributions of service utilisation and cost data
were checked for normality. Since, for most items, the
data were skewed (high proportions of participants with
zero usage, small numbers of participants with very high
usage), comparisons were conducted using medians and
inter-quartile range, and Mann Whitney U tests. Utilisa-
tion and costs of users and non-users of the RRS were
compared for each service use category. The analysis
was conducted separately for each of the five time
periods that participants were in the study because it
was expected that service use and costs would correlate
positively with duration.Ethical approval
The study received a favourable ethical opinion from the
Kent Research Ethics Committee, reference 09/H1101/75.
The National Information Governance Board confirmed
patient consent was not needed for use of pseudo-
anonymised data sets.Results
Study participants
The 1704 patients newly referred to the hospice during the
18 month study period were evenly distributed between
the three centres (Fig. 2). Of these, 1527 (89.6 %) were
eligible. Amongst the 953 for whom a PPD was known,
there were 688 (72.2 %) who could potentially use the RRS
because they had been referred to the hospice during the
time the RRS was running in their area, and 265 who could
not (because there was no RRS service available – the
control group). Of the 688 who could access the RRS, 247
(35.9 %) received care from it (were RRS ‘users’) and
the rest did not (‘non-users’) (Fig. 2). The proportions
of users (vs. non-users) was lower in Area 3 (30.8 %)
Fig. 2 Recruitment by area. Analysis in this paper focuses on 247 users of RRS and 441 non users.
* Eligible if: had died at end of study; were not already registered with hospice when RRS introduced. PPD Preferred Place of Death
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(chi square, p = 0.601).
A comparison of the 953 people with a PPD and 574
excluded participants (no PPD) revealed no evidence of
differences with respect to age or sex. Those with a PPD
were more likely to have died at home than those with-
out a PPD (36.9 % vs. 24.7 %) and to live alone 241 (26.2
% vs. 15.9 %) (chi sq. p < .001, both comparisons).
Comparison of 247 RRS users with 441 non-users
There were no significant differences between users and
non-users with respect to mean age, days in study andsex. However, users were significantly more likely than
non-users to want to die at home, actually die at home,
and die where they wanted. Data on residential situation
were available for 586 (85.2 %) participants; higher pro-
portions of RRS users lived in their own homes with a
co-resident carer, and more non-users lived alone or in
residential care. Differences were found between initial
and follow-up PPD for only 12 participants (six per
group) (Table 1).
Comparing characteristics of users and non-users
(taken together) across the three areas, no significant
differences were found in age, gender, APD or achieving
Table 1 Comparison of characteristics of RRS users and non-users
Intervention group N = 688 (%) Non-user (N = 441) User (N = 247) P-value
Age at death (Mean, SD) 75.10 (12.21) 75.10 (10.22) T test 0.985
Days in study (Mean, SD) 69.1 (76.50) 73.1 (81.23) T test 0.521
Area 1 Canterbury 229 (51.9) 131 (53.0)
2 Thanet 158 (35.8) 92 (37.2)
3 Ashford 54 (12.2) 24 (9.7)
Sex Male 245 (55.6) 143 (57.9) χ2 0.553
Female 196 (44.4) 104 (42.1)
Initial PPDa Home 227 (51.5) 190 (76.9) χ2 < 0.0005
Care Home 47 (10.7) 2 (0.8)
Hospice 158 (35.8) 52 (21.1)
Hospital 4 (0.9) 0 (0)
Other 5 (1.1) 3 (1.2)
Final PPD Home 221 (50.1) 184 (74.5) χ2 < 0.0005
Care Home 47 (10.7) 3 (1.2)
Hospice 164 (37.2) 58 (23.5)
Hospital 4 (0.9) 0 (0)
Other 5 (1.1) 2 (0.8)
APDa Home 114 (26.3) 156 (63.2) χ2 < 0.0005
N = 434 non-users Care Home 65 (15.0) 11 (4.5)
Hospice 200 (46.1) 61 (24.7)
Hospital 55 (12.7) 19 (7.7)
Residential situation At Home not alone 218 (58.8) 164 (76.3) χ2 < 0.0005
N = 371 non-users At home alone 103 (27.8) 48 (22.3)
N = 215 users Residential care 50 (13.5) 3 (1.4)
Achieving PPD (using initial PPD) Yes 257 (59.2) 171 (69.2) χ2 0.009
N = 434 non-users No 177 (40.8) 76 (30.8)
APD Actual Place of Death
PPD Preferred Place of Death
aEach care home resident whose PPD (n = 47) and/or APD (n = 31) was recorded as ‘home’ in the hospice database was individually investigated to assess whether
this referred to the ‘care home’ or to their own independent accommodation so that it could be appropriately coded. Following enquiries all APD, and, except for
four PPD, were found to be ‘care home’
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location) was significantly higher in Area 1 than in Areas
2 or 3 (65.0 % vs. 56.0 %, 55.1 %, p = .016 for initial PPD,
62.8 % vs. 56.4 %, 48.7 %, p = .004 for final PPD).
Died where wanted
The APD was not known for 7 non-users. Of the
remaining 681 participants, 171 (69.2 % of 247 RRS users)
and 257 (59.2 % of 434 RRS non-users) died in the pre-
ferred place they initially stated (p = 0.009). Of 190 users
of the RRS wanting to die at home, 141 (74.2 %) achieved
that, compared to 96 of 223 (43.0 %) non-users (p
<0.0005) (Table 2).
Bivariate analysis showed that the proportion who
achieved their PPD varied depending on PPD, being
highest for people wanting to die in the hospice, or a
care home (most of whom were already resident in acare home). Being in the study for a longer length of
time (more days between referral to the hospice and
death) reduced the chances of dying in the initial PPD.
Age and area of residence were not significantly associ-
ated with achieving PPD (Table 3).
Regression modelling showed that being a RRS user
enhanced the chances of dying where initially wanted
2.1 times compared to being a RRS non-user. A person
living at home with a co-resident carer (i.e. not alone)
was 1.5 times more likely to achieve their PPD com-
pared to anyone living at home alone or in a care home.
Stating an initial PPD as a care home afforded a 7.7
times greater chance of achieving their PPD compared
to those with a PPD in any other location. Stating an ini-
tial PPD as own home afforded a 0.55 times less chance
of achieving PPD than stating a PPD in any other loca-
tion (Table 4).
Table 2 Comparison of actual and preferred place of death
Achieved PPD shown on
diagonal
APD
Home Care Home Hospice Hospital Total
Group Initial PPD N % N % N % N % N
Non user Home 96 43.0 9 4.0 79 35.4 39 17.5 223
Care Home 1 2.1 43 91.5 1 2.1 2 4.3 47
Hospice 15 9.7 12 7.7 117 75.5 11 7.1 155
Hospital 1 25.0 0 0 2 50.0 1 25.0 4
Other 1 20.0 1 20.0 1 20.0 2 40.0 5
Total 114 26.3 65 15.0 200 46.1 55 12.7 434
User Home 141 74.2 2 1.1 33 17.3 14 7.3 190
Care Home 0 0 2 100.0 0 0 0 0 2
Hospice 14 26.9 5 9.6 28 53.8 5 9.6 52
Other 1 33.3 2 66.7 0 0 0 0 3
Total 156 63.2 11 4.5 61 24.7 19 7.7 247
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Users of the RRS had higher use of GP, community,
Marie Curie and out-of-hours services than RRS non-
users; the difference was significant for some time pe-
riods and services. Non-users tended to have higher use
of acute hospital services (significant 3 – 14 day period)Table 3 Characteristics of those who achieved initial preferred place
Achieved PPD - NO (
N %
Area 1 120 3
2 100 4
3 33 4
Gender Female 100 3
Male 153 3
Days in study 0-2 4 1
3-14 30 2
15-30 36 3
31-60 54 3
>60 129 4
Initial PPD Own home 176 4
Care home 4 8
Hospice 62 3
Hospital 3 7
Other 8 1
Achieved PPD - NO (
Residential situation Own home not alone 146 3
Own home alone 69 4
Care home 10 1and hospice services other than the RRS (significant 15-
30 day period) than the RRS users (Table 5).
The pattern of costs for users and non-users reflects
service utilisation. The large cost items are primary,
community, hospice and hospital inpatient stays. As
expected, costs increase as duration of time in the studyof death
N = 253) Achieved PPD – YES (N = 428) Significant
difference
(p)
N %
3.7 236 66.3
0.5 147 59.5 χ2 0.144
2.3 45 57.7
3.7 197 66.3 χ2 0.098
9.8 231 60.2
0.0 36 90.0
5.4 88 74.8 χ2 < 0.0005
0.5 82 69.5
7.2 91 62.8
9.6 131 50.4
2.6 237 57.4
.2 45 91.8 χ2 < 0.0005
0.0 145 70.0
5.0 1 25.0
00.0 0
N = 225) Achieved PPD – YES (N = 354)
8.7 231 63.1
6.3 80 53.7 χ2 0.002
8.9 43 81.1
Table 4 Stepwise (backward elimination) logistic regression
modelling of achieving PPD (Yes/No)
Variable Odds Ratio (OR) p 95 % CI for OR
Lower Upper
Live at home with carer 1.505 .050 1.001 2.263
Area 3 0.542 .036 0.306 0.959
RRS user (vs. non-user) 2.099 <.0005 1.430 3.081
Days in study (between
referral to hospice
and death)
0.983 <.0005 0.977 0.989
Initial PPD is home 0.548 .005 0.362 0.830
Initial PPD is care home 7.708 <.0005 2.531 23.470
Constant 2.894 <.0005
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service, so the median number of visits to people with
different times in the study was similar (overall median:
11 visits; cost £425). There was no significant difference
in the total service costs of users and non-users for any
time period, except, amongst those referred to the hos-
pice within 2 days of death, when RRS users had signifi-
cantly higher overall cost of services than non-users due
to the RRS input and other community care costs
(Table 6).
Discussion
The study was based on people referred to a large hos-
pice provider and focussed on a comparison of users
and non-users of a new RRS that was rolled out in
phases across three areas. When the RRS was available
in an area, some 36 % of hospice clients accessed it.
Users were more likely than non-users to live in their
own homes with a co-resident carer and have expressed
a wish to die at home. Overall there was no difference in
the whole system costs of RRS users and non-users, ex-
cept RRS users referred to the hospice within two days
of death incurred significantly higher total costs than
non-users in the study for the same period of time. Hos-
pice patients who did not use the RRS relied on all the
other hospice services more than RRS users, but, con-
sistent with some other evidence [20], RRS users had
higher utilisation of other health services than non-
users.
Amongst the 953 patients for whom a PPD was
known, there was no significant difference between the
intervention and control arms of the study in the pro-
portions who died in their preferred place (428 of 688,
62.8 % in the intervention group, 164 of 265 in the con-
trol group, chi squared p = .724) [17]. However, within
the intervention group, significantly higher proportions
of RRS users than non-users achieved their PPD (69 %
vs. 59 %). In particular, people wanting a home death
were more likely to achieve it if they had access to theRRS (74 % users vs. 43 % non-users). Being a RRS user
more than doubled a participant’s chances of dying
where they wanted. Other studies set in the UK have
also found that RRS results in higher proportions of pa-
tients dying at home [10, 14, 15]. This might reflect se-
lection bias, i.e. only people where health professionals
perceive the RRS could make a difference are offered ac-
cess to it.
Having a co-resident carer also increased the chances
(one and half times) of dying in the preferred location,
reflecting the well-recognised problems of facilitating
the wish to die at home of people who live alone [21]. In
supporting carers to minimise the adverse effects of their
role [22], the RRS may prevent carer breakdown and un-
planned use of inpatient services. The group most likely
to die where they wanted was care home residents, most
of whom were deemed to have wanted to die in their
care home, and achieved that wish. It should be noted,
however, that ambiguities in the hospice data that re-
corded the wishes of some care home residents as being
to die at ‘home’ were interpreted by the researchers (after
case-by-case investigation) as meaning ‘care home’.
Patients who were referred to the hospice further from
death, and who wanted to die at home, were less likely
to achieve that than those referred to the hospice closer
to death and those who wanted to die somewhere other
than their own home. The analysis was based on initial
PPD as recorded in the hospice notes, and lower propor-
tions dying where they wanted amongst people in the
study longer could have arisen because changes in
wishes were not recorded. It is known that preferences
change, even in the last hours [23], with lower propor-
tions wanting to die at home as death approaches [5].
Wishes are influenced by unforeseen experiences, the
views and health of family carers and by the care process
itself, e.g. the availability of technology at home. The ex-
tent to which changes in patients’ wishes as death
approached were captured in this study is not known.
Analysis revealed differences between the initial and
final wishes in only 12 participants, but recording of
changes of preference was not reliable, and it is possible
that changes to the initial PPD were overwritten in
notes. Although meeting individual’s PPD is a suggested
national outcome for palliative services [8, 24], its use in
practice, and in research, presents challenges and find-
ings based on it, including statistics on achieving PPD,
should be interpreted with caution.
The RRS was delivered by the same team in all three
areas and data were aggregated for analysis. Prior to the
service being rolled out in each area, additional HCAs
were recruited. The RRS worked as a team, and each
HCA visited patients across all three areas [18].
Although patients did not differ between areas in age,
sex, residential situation, and length of time in the study,
Table 5 Total service use: comparison of RRS users (N = 247) and non-users (N = 441), by days in the study
Days in study (time between referral to hospice and death)
Service type 0-2 days 3-14 days 15-30 days 31-60 days >60 days
Study Group Non-User User Non-User User Non-User User Non-User User Non-User User
Number in Group 17 7 52 28 37 30 58 36 103 58
All GP/primary contactsa No (%) with > =1 contact 5 (29.4) 4 (57.1) 22 (42.3) 19 (67.9) 25 (67.6) 27 (90.0) 46 (79.3) 33 (91.7) 94 (91.3) 56 (96.6)
Median contacts, IQR 0,0-1 1,0-1 0,0-1 1,0-3 1,0-2 2,0.1-2 2,0-4 2.5,0.7-4 4,1-8 6,1.9-8.5
MWU 0.285 0.011 0.078 0.539 0.031
Number in Group 31 9 76 42 66 52 100 47 168 97
All Community contactsb No (%) with > =1 contact 16 (51.6) 8 (88.9) 36 (47.4) 34 (81.0) 39 (59.1) 45 (86.5) 83 (83.0) 43 (91.5) 132 (78.6) 93 (95.9)
Median contacts, IQR 1,0-4 7,0-8 0,0-5 11.5,0-17 2.6,0-7.5 13.5,0-21.25 7.5,0-15.75 15,0.80-34 12,0-30.5 26,5-43
MWU 0.024 0.000 0.000 0.004 0.000
All Acute contactsc No (%) with > =1 contact 1 (3.2) 0 (0) 19 (25.0) 3 (7.1) 30 (45.5) 19 (36.5) 64 (64.0) 25 (53.2) 135 (80.4) 82 (84.5)
Median contacts, IQR 0,0-0 0,0-0 0,0-0.75 0,0-0 0,0-2 0,0-1.75 1,0-7.75 1,0-5 6,0-15 4,0-12
MWU 0.590 0.014 0.426 0.369 0.231
All Marie Curie visitsd No (%) with > =1 contact 1 (3.2) 0 (0) 0 (0) 7 (16.7) 0 (0) 9 (17.3) 2 (2.0) 5 (10.6) 3 (1.8) 12 (12.4)
Median visits, IQR 0,0-0 0,0-0 0,0-0 0,0-0 0,0-0 0,0-0 0,0-0 0,0-0 0,0-0 0,0-0
MWU 0.590 0.000 0.000 0.022 0.000
All Out-of-hours contactse No (%) with > =1 contact 2 (6.5) 2 (22.2) 8 (10.5) 16 (38.1) 11 (16.7) 18 (34.6) 20 (20.0) 17 (36.2) 43 (25.6) 46 (47.4)
Median contacts, IQR 0,0-0 0,0-0 0,0-0 0,0-1 0,0-0 0,0-1.75 0,0-0 0,0-1 0,0-1 0,0-2
MWU 0.170 0.000 0.016 0.034 0.000
Hospice Contactsf, not RRS No (%) with > =1 contact 31 (100) 9 (100) 76 (100) 42 (100) 66 (100) 52 (100) 100 (100) 47 (100) 168 (100) 97 (100)
Median contacts, IQR 1,1-3 1,1-1.5 4,1-7.75 3,1-4 10,1.7-16.2 3.5,2-6 4.5,2-13.5 6,2-13 11,2-28 13,4-26.5
MWU 0.170 0.404 0.000 0.161 0.302
Social servicesg No (%) > =1 service 1 (3.2) 1 (11.1) 8 (10.7) 3 (7.1) 5 (7.6) 9 (17.3) 22 (22.0) 6 (12.8) 24 (14.3) 21 (81.6)
MWU 0.345 0.536 0.104 0.158 0.167
Hospice RRS No (%) used RRS 0 9 (100) 0 42 (100) 0 52 (100) 0 47 (100) 0 97 (100)
Median visits, IQR 4,1-8 11,2-23 9.50,1-27 12,1-33 14,1.8-33.5
Median hours, IQR 8,4-9.2 15.1,4-28.4 10,2-31.5 12.7,2.9-50.4 18,2-47.9
Notes:
aSum of patient visits to surgery to see GP or practice nurse, and home visits by GP
bSum of visits and telephone calls to patient by community nurse, long term condition team, intermediate care teams, community matron
cSum of visits to hospital A&E, inpatient nights, outpatient appointments, day hospital visits
dNumber of Marie Curie health care assistants or registered nurse visits; each lasted 8 h (overnight sitting)
eSum of out of hours home visits by GP or nurse, telephone advice by GP, ‘walk-in’ attendances, and ambulance responses
fAll participants had been referred to the hospice. Hospice services include: home or outpatient contacts with hospice nurses, doctors, allied health professionals, social worker, chaplain; inpatient stays; day hospice
attendances for complementary therapies
gNumber of social services received (e.g. domiciliary help, meals)
MWU Mann Whitney U test
IQR is displayed as the explicit 25 % - 75 % values
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Table 6 Costs of services received £2010b : Comparison of RRS users (N = 247) and non-users (N = 441), by days in the study
Median (inter- quartile
range, 75th – 25th),
Days in study (time between referral to hospice and death)
0-2 days 3-14 days 15-30 days 31-60 days >60 days
Study group Non-user User Non-user User Non-user User Non-user User Non-user User
Number in group 31 9 76 42 66 52 100 47 168 97
All GP/primarycontacts 65 (65) 65 (120) 120 (123) 123 (117)a 189 (69) 189 (48) 339 (217) 339 (240) 525 (273) 525 (218)a
All community contacts 27 (108) 189 (135)a 0 (133) 302 (375)a 63 (200) 364 (390)a 209 (378) 378 (814)a 331 (773) 737 (777)a
All acute (hospital) contacts 0 (0) 0 (0) 0 (54)a 0 (0) 0 (274) 0 (137) 93 (2718) 72 (1700) 1064 (4025) 900 (2943)
All Marie Curie visits 0 (0) 0 (0) 0 (0) 0 (0)a 0 (0) 0 (0)a 0 (0) 0 (0)a 0 (0) 0 (0)a
All Out-of-hours contacts 0 (0) 0 (0) 0 (0) 0 (41)a 0 (0) 0 (81)a 0 (0) 0 (41)a 0 (33) 0 (122)a
All hospice contacts,
not RRS
90 (324) 90 (45) 504 (2056) 241 (365) 2512(5056)a 274 (511) 360 (1889) 605 (2919) 1694 (8016) 1172 (5707)
All social services 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)a 0 (0) 0 (0) 0 (0) 0 (0)
Hospice RRS visits 0 (0) 160 (240)a 0 (0) 440 (721)a 0 (0) 380 (951)a 0 (0) 480 (1161)a 0 (0) 560 (1181)a
Total of 8 services 367 (262) 690 (291)a 1372 (2102) 1548 (1278) 3790 (4409) 2204 (2523) 3809 (6859) 5110 (5461) 7298(11327) 7324 (7951)
aMann Whitney U test, significantly higher than the other group, p < 0.05
bUnit costs of health care, inclusive of oncosts and overheads, applied to service utilisation [19]. GP/Primary: GP/nurse surgery consultations £36/£7.75, GP home visits £120. Community: home visit by nurse/long term
conditicns or intermediate care team £27/£31.40, telephone call by long term conditions or intermediate care team £10.00. Acute: A&E £114, outpatient consultation £72, day hospital £194, inpatient night £425. Marie
Curie health care assistant/nurse visit: £32/£64. Out-of hours: GP/home visit £180 / £40.50, GP telephone advice £33, walk-in clinic £37, ambulance £90. Hospice costs (based on NHS costs following discussion with hos-
pice finance director), inclusive of oncosts and overheads: home visits by consultant/associate director/nurse/physician/associate practitioner/social worker or chaplain/physiotherapist or occupational therapist: £355/
£132/£90/£324/£40/£172/£225/£58; outpatient consultations with consultant/nurse/physician/associate practitioner/social worker: £213.40/£28/£140/£5.25/£106.50; inpatient days: £425; day hospice: £194; counselling:
£53.25; breathlessness therapy: £38; complementary therapies (varied): £25.75; RRS: £40 per visit (two visits counted when two HCAs attended)
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Gage et al. BMC Palliative Care  (2015) 14:75 Page 10 of 11higher proportions of patients in Area 1 expressed a
wish to die at home, and participants in Area 3 had a
lower chance of dying in their preferred place, after con-
trolling for all other factors. Reasons underlying these
differences are not known, but may reflect differing
socio-economic profiles of the areas.
The study meets a well-recognised need for informa-
tion on end-of-life costs to inform service commission-
ing [5, 8, 10–12] and provides unique information on
whole system utilisation of services in the days/weeks
leading up to death. The data were meticulously collected
from hospice records and directly from providers, and the
findings confirm the high resource use of palliative care
[25]. However, unlike some other studies [10, 26–29],
provision of the RRS was not associated with lower overall
costs, and this may reflect the particular context in which
this RRS was delivered and the patient group it covered.
Decisions about who was offered the RRS were usually
made by hospice clinical staff based on whether immedi-
ate end-of-life care was needed (prognosis less than 72 h)
or for crisis intervention (sudden deterioration or carer
breakdown). People receiving the RRS were dispropor-
tionately those with co-resident carers, had expressed a
wish to die at home and had high utilisation of other
services. Some other specialist palliative care services have
different referral criteria, for example, only including
people wanting to die at home [28]. From a commission-
ing perspective, it is interesting to note that non-users of
the RRS tended to have higher utilisation of hospital and
other hospice services, and further work is needed to
explore this trend.
Methodological and ethical challenges confront research
in the palliative care arena, and specific problems are asso-
ciated with randomisation, and measuring quality of life
and outcomes [30–32]. Particular difficulties exist in cal-
culating palliative care costs [8, 10, 11] due to problems
defining when end-of-life starts [33], and the fragmenta-
tion of service use data across providers [26, 34]. This
study took a pragmatic approach and utilised the
opportunity provided by the introduction of a new RRS
(a natural experiment) to evaluate its impact on achiev-
ing PPD and costs. Performing a retrospective power
calculation, based on detecting a 10 % difference
between users and non-users of the RRS in achieving
PPD, the sample sizes (247 vs. 434) provided good
power (74.2 % for a 2-sided test).
However, it has several limitations. It only includes
people referred to a hospice, and this group may not be
representative of all people receiving community pallia-
tive care. People with no recorded PPD were excluded,
and this group was less likely to have died at home and
live alone than those with a PPD, so the sample analysed
was not entirely typical of the whole hospice population.
Service use data and costs were analysed in five timeperiods which were determined post hoc. Experimenta-
tion suggested that a finer (weekly) division (13 time
periods) was impractical because the group sizes were
too small for meaningful analysis. The five groups identi-
fied provided approximately even numbers of participants
(except the open-ended longest period), but different
groupings could have affected the findings. Some GPs did
not provide service use data (affected 37 % of participants)
and use of mean imputation may have introduced inaccur-
acies. The costs of the RRS may be underestimated since
they were based on visits lasting one hour, and some-
times staff stayed longer (e.g. night sitting). Travel costs
(averaged £12 per visit) were not included since they
varied with the location of the patient’s home. The bur-
den of a home death on family carers was not calcu-
lated although evidence shows this exceeds the cost of
formal services [35]. No measure of quality of care was
included although interviews with a sample of carers in
the study identified that care providers have an import-
ant influence on a ‘good death’ [36].Conclusions
The benefits of an integrated care system to address the
multiple and diverse needs of people at the end of life
are recognised [37], and a RRS plays an important role
within that system by increasing choice and reducing
the fragmentation of services that is a source of distress
to patient and carers [5, 8, 11, 38–40]. Amongst pa-
tients referred to the hospice in this study, those with a
co-resident family carer and who had expressed a wish
to die at home were most likely to receive care from
the RRS. The provision of the RRS that worked in co-
operation with other local services did not affect the
whole system costs of providing palliative care. Analysis
of users compared to non-users produced evidence that
the RRS supports people to die where they want, espe-
cially if that is in their own home. But there is a high
likelihood of bias in the selection of patients who re-
ceive access to the RRS. Supply side factors, however,
also affect outcomes, and resource constraints may
have restricted access to the service and affected the
proportions dying in their preferred place. Since the
service was observed to be cost neutral, a case exists
for widening access to it.Abbreviations
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